146 related articles for article (PubMed ID: 24146277)
1. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene Ala222Val and susceptibility to ovary cancer: a systematic review and meta-analysis.
Pan X; Lu Y; Long Y; Yao D
Tumour Biol; 2014 Mar; 35(3):2133-9. PubMed ID: 24146277
[TBL] [Abstract][Full Text] [Related]
2. Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies.
Yu L; Chen J
Diagn Pathol; 2012 Dec; 7():171. PubMed ID: 23217001
[TBL] [Abstract][Full Text] [Related]
3. Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis.
Li K; Hu Yp; Yang Z; Sun T
Tumour Biol; 2013 Oct; 34(5):2565-72. PubMed ID: 23649653
[TBL] [Abstract][Full Text] [Related]
4. MTHFR-Ala222Val and male infertility: a study in Iranian men, an updated meta-analysis and an in silico-analysis.
Nikzad H; Karimian M; Sareban K; Khoshsokhan M; Hosseinzadeh Colagar A
Reprod Biomed Online; 2015 Nov; 31(5):668-80. PubMed ID: 26380869
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of the association between MHTFR C677T (rs1801133, Ala222Val) polymorphism and susceptibility to bladder cancer.
Xu W; Zhang H; Wang F; Wang H
Diagn Pathol; 2013 Jun; 8():95. PubMed ID: 23773402
[TBL] [Abstract][Full Text] [Related]
6. Associations between MTHFR Ala222Val polymorphism and risks of hepatitis and hepatitis-related liver cancer: a meta-analysis.
Zheng R; Zhao W; Dai D; Li C
Tumour Biol; 2014 Feb; 35(2):1313-8. PubMed ID: 24155211
[TBL] [Abstract][Full Text] [Related]
7. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
Ma C; Liu Y; Zhang W; Liu P
Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
[TBL] [Abstract][Full Text] [Related]
8. The effect of MTHFR ala222val polymorphism on open-angle glaucoma: a meta-analysis.
Zhao R; Yin D; Wang E; Si B
Ophthalmic Genet; 2015 Mar; 36(1):27-30. PubMed ID: 25317717
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.
Zhang Y; Chen GQ; Ji Y; Huang B; Shen WS; Deng LC; Xi L; Cao XM
Mol Biol Rep; 2012 May; 39(5):6203-11. PubMed ID: 22215214
[TBL] [Abstract][Full Text] [Related]
10. Association between maternal, fetal and paternal MTHFR gene C677T and A1298C polymorphisms and risk of recurrent pregnancy loss: a comprehensive evaluation.
Yang Y; Luo Y; Yuan J; Tang Y; Xiong L; Xu M; Rao X; Liu H
Arch Gynecol Obstet; 2016 Jun; 293(6):1197-211. PubMed ID: 26530235
[TBL] [Abstract][Full Text] [Related]
11. Relationship between methylenetetrahydrofolate reductase (MTHFR) gene (A1298C) polymorphism with the risk of stroke: A systematic review and meta-analysis.
Kumar A; Sharma R; Misra S; Nath M; Kumar P
Neurol Res; 2020 Nov; 42(11):913-922. PubMed ID: 32727306
[TBL] [Abstract][Full Text] [Related]
12. MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
Shi XY; Shen Q
Genet Mol Res; 2015 Jul; 14(3):8211-8. PubMed ID: 26345746
[TBL] [Abstract][Full Text] [Related]
13. ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.
Liu W; Li Y; Li R; Han X; Ma Y; Liu B; Kong X
Afr J Tradit Complement Altern Med; 2016; 13(5):72-86. PubMed ID: 28487897
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between MTHFR Ala222Val and Glu429Ala polymorphisms and bladder cancer risk: A meta-analysis of case-control studies.
Shi R; Zhao Z; Zhou H; Zhou J; Tan W
Biomed Rep; 2014 May; 2(3):396-403. PubMed ID: 24748982
[TBL] [Abstract][Full Text] [Related]
15. Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects.
Zhang J; Zhang L; Li G
World J Surg Oncol; 2016 Aug; 14(1):230. PubMed ID: 27568010
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility.
Qiu LX; Zhang J; Li WH; Zhang QL; Yu H; Wang BY; Wang LP; Wang JL; Wang HJ; Liu XJ; Luo ZG; Wu XH
Mol Biol Rep; 2011 Apr; 38(4):2295-9. PubMed ID: 21052845
[TBL] [Abstract][Full Text] [Related]
18. Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.
Karimi-Zarchi M; Moghimi M; Abbasi H; Hadadan A; Salimi E; Morovati-Sharifabad M; Akbarian-Bafghi MJ; Zare-Shehneh M; Mosavi-Jarrahi A; Neamatzadeh H
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2569-2577. PubMed ID: 31554347
[TBL] [Abstract][Full Text] [Related]
19. MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.
Ding XP; Feng L; Ma L
Asian Pac J Cancer Prev; 2012; 13(8):3937-42. PubMed ID: 23098496
[TBL] [Abstract][Full Text] [Related]
20. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
